The Lancet Haematology at 10.

IF 15.4 1区医学 Q1 HEMATOLOGY Lancet Haematology Pub Date : 2024-10-01 DOI:10.1016/S2352-3026(24)00289-8

Lan-Lan Smith, Yaiza Del Pozo Martín, Emma Cookson

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

柳叶刀血液学》第 10 期。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Lancet Haematology HEMATOLOGY-

CiteScore

26.00

自引率

0.80%

发文量

323

期刊介绍： Launched in autumn 2014, The Lancet Haematology is part of the Lancet specialty journals, exclusively available online. This monthly journal is committed to publishing original research that not only sheds light on haematological clinical practice but also advocates for change within the field. Aligned with the Lancet journals' tradition of high-impact research, The Lancet Haematology aspires to achieve a similar standing and reputation within its discipline. It upholds the rigorous reporting standards characteristic of all Lancet titles, ensuring a consistent commitment to quality in its contributions to the field of haematology.

期刊最新文献

Time to optimise management of haemolytic disease of the fetus and newborn. Variations in antenatal management and outcomes in haemolytic disease of the fetus and newborn: an international, retrospective, observational cohort study. Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial. Accelerating and optimising CAR T-cell manufacture to deliver better patient products. Management of pregnancies with anti-K alloantibodies and the predictive value of anti-K titration testing.